Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.
Stimdia Medical has raised $16.0M in total funding. The most recent round was Series B. The last funding was announced in July 2022.
Stimdia Medical's investors include Solas BioVentures, Draper Triangle.
Stimdia Medical is headquartered in Eagan, United States.
Stimdia Medical is a developer of a lung pacing device intended to facilitate weaning patients from mechanical ventilation.
Stimdia Medical is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stimdia Medical — Funding & Investors." VCBacked, July 14, 2022, https://www.vcbacked.co/company/stimdia-medical. Accessed September 30, 2026.
VCBacked. (2022). Stimdia Medical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/stimdia-medical
{{cite web |title=Stimdia Medical — Funding & Investors |url=https://www.vcbacked.co/company/stimdia-medical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated